Pacific Biosciences of California, Inc. Financial Ratios — P09

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-46.42	-62.8	-88.81	-106.6	-49.34	-94.02	-107.97	-102.48	-99.58	15.06	-32.18	-46.42	-48.53	-51.3	-213.45
Return on Assets (%)	-41.75	-54.29	-59.65	-50.78	-24.81	-55.3	-65.39	-65.25	-52.87	10.46	-14.97	-16.65	-17.46	-20.61	-53.45
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	12.01	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-42.25	- -	- -	- -	- -	- -
Gross Margin (%)	38.49	3.62	22.78	38.62	57.61	48.68	37.08	31.92	38.04	41.28	45.1	38.22	26.32	24.21	28.61
EBITDA Margin (%)	-306.98	-337.49	-255.12	-96.76	-27.44	-74.27	-87.03	-119.26	-99.68	-120.52	-152.36	-225.93	-153.57	-273.33	-104.65
Operating Margin (%)	-324.12	-363.08	-275.16	-103.73	-56.24	-78.54	-96.06	-128.44	-110.62	-132.31	-136.51	-237.58	-154.78	-188.73	-348.46
Incremental Operating Margin (%)	94.68	- -	764.1	45.32	33.17	922	- -	75.48	3.6	32.01	- -	5,733.64	- -	- -	- -
Pretax Margin (%)	-323.03	-363.56	-281.37	-109.19	-34.16	-81.99	-98.63	-130.44	-92.57	37.27	-210.61	-244.92	-158.67	-200.98	-341.28
Profit Margin (%)	-323.03	-363.56	-281.37	-109.19	-34.16	-81.99	-98.63	-130.44	-92.57	37.27	-138.85	-244.92	-152.97	-201.18	-341.47
Net Income to Common Margin (%)	-323.03	-363.56	-281.37	-109.19	-34.16	-81.99	-98.63	-130.44	-92.57	37.27	-138.85	-244.92	-152.97	-201.18	-341.47
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-46.42	-62.8	-88.81	-106.6	-49.34	-94.02	-107.97	-102.48	-99.58	15.06	-32.18	-46.42	-48.53	-51.3	-213.45

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	3	3	14	14	15	16	14	15	62	42	955	948	934	672	702
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	20	4	9	11	10	10	- -
LT Debt	3	3	13	14	15	16	14	15	42	38	946	938	924	662	702
Total Debt/EBITDA	-0.03	-0.03	-0.19	-0.24	-0.59	-0.24	-0.17	-0.16	-0.68	-0.44	-4.8	-3.27	-3.03	-1.6	-4.19
Net Debt/EBITDA	0.57	0.53	0.18	0.38	0.73	0.01	0.04	0.04	0.15	0.86	-2.2	-1.98	-2.31	-1.41	-3.47
Total Debt/EBIT	-0.03	-0.03	-0.17	-0.22	-0.51	-0.23	-0.15	-0.15	-0.61	-0.4	-4.54	-3.09	-2.79	-1.42	-1.27
Net Debt/EBIT	0.54	0.49	0.17	0.36	0.64	0.01	0.03	0.04	0.14	0.78	-2.08	-1.87	-2.13	-1.25	-1.05
EBITDA to Interest Expense	-362.21	-320.03	-29.01	-20.73	-8.7	-20.83	-27.85	-38.7	-34.7	-356.11	-15.87	-19.73	-21.47	-31.39	-24.08
EBITDA-CapEx/Interest Expense	-394.55	-326.25	-29.38	-21.3	-9.73	-23.37	-31.42	-39.47	-35.78	-360	-16.34	-20.89	-22.09	-31.85	-25.19
EBIT to Interest Expense	-382.43	-344.3	-31.29	-22.23	-17.83	-22.03	-30.74	-41.68	-38.51	-390.96	-14.22	-20.75	-21.64	-21.67	-80.18
Interest Expense	- -	- -	2	3	3	3	3	2	3	- -	13	15	14	13	7
Common Equity/Total Assets	87.7	84.35	50.8	44.17	56.09	61.41	59.76	66.99	37.11	81.04	39.41	31.85	40.17	40.19	0.68
Long-Term Debt/Equity (%)	1.46	2.39	19.29	25.46	20.33	19.02	15.84	12.85	76.41	11.23	119.6	166.59	131.73	130.76	13,123.46
Long-Term Debt/Capital (%)	1.43	2.33	16.13	20.29	16.89	15.98	13.67	11.39	35.99	9.98	54.17	62.05	56.5	56.18	99.18
Long-Term Debt/Total Assets (%)	1.28	2.01	9.8	11.25	11.4	11.68	9.46	8.61	28.36	9.1	47.14	53.07	52.91	52.55	89.53
Total Debt/Equity (%)	1.53	2.55	19.6	25.46	20.33	19.02	15.84	12.85	112.3	12.52	120.78	168.5	133.17	132.74	13,131.84
Total Debt/Capital (%)	1.51	2.48	16.39	20.29	16.89	15.98	13.67	11.39	52.9	11.13	54.71	62.76	57.11	57.03	99.24
Total Debt/Total Assets (%)	1.34	2.15	9.95	11.25	11.4	11.68	9.46	8.61	41.67	10.15	47.6	53.67	53.49	53.35	89.59
Net Debt to Equity	-30.74	-42.55	-18.81	-40.87	-25.4	-0.78	-3.34	-3.67	-25.05	-24.33	55.24	101.87	101.64	116.88	10,874.46
Net Debt/Capital (%)	-43.44	-70.91	-23.09	-69.12	-34.05	-0.78	-3.45	-3.81	-15.82	-27.58	33.99	48.34	48.98	52.7	90.31
EBITDA	-104	-88	-72	-59	-25	-67	-81	-94	-91	-95	-199	-290	-308	-421	-167
EBITDA-CapEx	-113	-89	-73	-60	-28	-76	-92	-96	-93	-96	-205	-307	-317	-427	-175
Operating Income (Loss)	-110	-94	-78	-63	-52	-71	-90	-101	-101	-104	-178	-305	-310	-291	-558

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	9.16	6.82	4.99	3.22	2.15	2.13	2.2	3.81	1	8.28	14.56	2.93	6.64	5.88	3.84
Current Ratio	10.3	7.8	5.61	3.74	2.9	3.23	3.55	4.9	1.65	9.24	15.36	3.24	7.81	7.48	5.15
Quick Ratio	9.39	7.01	5.11	3.33	2.55	2.62	2.66	4.13	1.31	8.72	14.9	3	7.03	6.3	4.32
CFO/Avg Current Liab	-5.12	-4.5	-1.6	-1.9	-1.37	-1.89	-2.16	-2.39	-2.06	0.44	-2.02	-1.57	-1.45	-2.55	-1.6
Common Equity/Total Assets	87.7	84.35	50.8	44.17	56.09	61.41	59.76	66.99	37.11	81.04	39.41	31.85	40.17	40.19	0.68
Long-Term Debt/Equity (%)	1.46	2.39	19.29	25.46	20.33	19.02	15.84	12.85	76.41	11.23	119.6	166.59	131.73	130.76	13,123.46
Long-Term Debt/Capital (%)	1.43	2.33	16.13	20.29	16.89	15.98	13.67	11.39	35.99	9.98	54.17	62.05	56.5	56.18	99.18
Long-Term Debt/Total Assets (%)	1.28	2.01	9.8	11.25	11.4	11.68	9.46	8.61	28.36	9.1	47.14	53.07	52.91	52.55	89.53
Total Debt/Equity (%)	1.53	2.55	19.6	25.46	20.33	19.02	15.84	12.85	112.3	12.52	120.78	168.5	133.17	132.74	13,131.84
Total Debt/Capital (%)	1.51	2.48	16.39	20.29	16.89	15.98	13.67	11.39	52.9	11.13	54.71	62.76	57.11	57.03	99.24
Total Debt/Total Assets (%)	1.34	2.15	9.95	11.25	11.4	11.68	9.46	8.61	41.67	10.15	47.6	53.67	53.49	53.35	89.59
CFO/Total Liabilities	-383.47	-378.41	-44.52	-74.12	-83.19	-127.65	-116.45	-118.17	-84.14	24.85	-9.14	-21.86	-24.81	-27.33	-14.28
CFO/CapEx	-11.09	-45.11	-32.82	-31.99	-15.92	-8.28	-6.47	-35.83	-27.61	18.77	-18.75	-15.55	-29.31	-33.3	-14.42
Altman's Z-Score	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-10.89

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	13.83	7.92	11.86	19.7	21.45	10.89	7.52	7.14	7.62	4.91	6.35	5.96	7.24	4.8	5.08
Days Sales Outstanding	26.4	46.11	30.79	18.53	17.02	33.53	48.53	51.13	47.91	74.26	57.44	61.2	50.42	76	71.83
Inventory Turnover	1.86	1.99	2.22	3.48	3.53	3.5	3.04	2.61	3.61	3.36	3.69	2.11	2.76	2.02	2.11
Days Inventory Outstanding	196.1	182.98	164.72	104.94	103.43	104.23	120.09	139.59	101.08	108.5	98.9	172.63	132.24	180.47	172.62
Accounts Payable Turnover	4.14	4.95	9.45	10.51	7.52	7.82	7.59	6.11	6.85	7.91	11.25	9.12	11.37	7.51	5.61
Accounts Payable Turnover Days	88.25	73.79	38.64	34.74	48.53	46.69	48.08	59.76	53.27	46.15	32.44	40.01	32.1	48.62	65.09
Cash Conversion Cycle	134.24	155.3	156.86	88.72	71.92	91.07	120.54	130.96	95.72	136.61	123.89	193.82	150.57	207.85	179.36
Inventory to Cash Days	-169.7	-136.87	-133.93	-86.41	-86.41	-70.7	-71.56	-88.46	-53.17	-34.24	-41.46	-111.42	-81.82	-104.46	-100.79
Inventories	16	10	10	11	11	16	23	18	13	14	25	50	57	59	49
Raw Materials	5	4	3	3	4	5	9	6	4	4	8	24	32	45	39
Work In Process	5	3	4	6	4	7	10	7	5	7	9	14	28	22	27
Finished Goods	5	2	3	2	3	4	4	4	5	4	8	12	16	14	16
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	514
- Cash & Cash Equivalents	59	47	26	36	34	17	17	19	30	82	461	325	180	55	64
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	3	3	14	14	15	16	14	15	62	42	955	948	934	672	702
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	937
Total Capital	194	112	83	69	88	101	100	129	117	377	1,746	1,511	1,635	1,179	708
Total Debt/Capital (%)	1.51	2.48	16.39	20.29	16.89	15.98	13.67	11.39	52.9	11.13	54.71	62.76	57.11	57.03	99.24
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.86
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	511
Diluted Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	934
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.1
TTM Sales	34	26	28	61	93	91	93	79	91	79	131	128	201	154	160
TTM EBITDA	-104	-88	-72	-59	-25	-67	-81	-94	-91	-95	-199	-290	-308	-421	-167
TTM Operating Income	-110	-94	-78	-63	-52	-71	-90	-101	-101	-104	-178	-305	-310	-291	-558
TTM Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	20	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	19	- -	- -	- -	- -	- -

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.3
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	937
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.52
EV/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.86
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	96.17
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.33
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	150.82
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	85.67
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.57
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.88
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2.46
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1.4
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.19
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3.83
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.01
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.85
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.6
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.51
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-7.21
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-4.09
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-5.15
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-6.74
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-3.83
EV/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.5
EV/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.68
EV/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.51
EV/EBITDA Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1.7
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.67
Enterprise Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,040
Enterprise Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,230
Enterprise Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	881

Shares Outstanding	55	56	66	74	80	93	116	150	153	192	221	227	268	294	302
Diluted Weighted Avg Shares	54	56	63	70	76	89	106	135	153	175	204	225	254	288	300
Basic Weighted Avg Shares	54	56	63	70	76	89	106	135	153	165	204	225	254	274	300
Revenue per Share	0.63	0.47	0.45	0.86	1.23	1.02	0.88	0.58	0.6	0.48	0.64	0.57	0.79	0.56	0.53
EBITDA per Share	-1.93	-1.57	-1.15	-0.83	-0.34	-0.76	-0.77	-0.69	-0.59	-0.58	-0.97	-1.29	-1.21	-1.53	-0.56
Operating Income per Share	-2.04	-1.69	-1.24	-0.89	-0.69	-0.8	-0.85	-0.75	-0.66	-0.63	-0.87	-1.36	-1.22	-1.06	-1.86
Basic EPS, GAAP	-2.03	-1.69	-1.26	-0.94	-0.42	-0.83	-0.87	-0.76	-0.55	0.18	-0.89	-1.4	-1.21	-1.13	-1.82
Basic EPS from Cont Ops	-2.03	-1.69	-1.26	-0.94	-0.42	-0.83	-0.87	-0.76	-0.55	0.18	-0.89	-1.4	-1.21	-1.13	-1.82
Diluted EPS, GAAP	-2.03	-1.69	-1.26	-0.94	-0.42	-0.83	-0.87	-0.76	-0.55	0.17	-0.89	-1.4	-1.21	-1.07	-1.82
Diluted EPS from Cont Ops	-2.03	-1.69	-1.26	-0.94	-0.42	-0.83	-0.87	-0.76	-0.55	0.17	-0.89	-1.4	-1.21	-1.07	-1.82
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-1.91	-1.38	-0.48	-0.73	-0.63	-0.76	-0.64	-0.49	-0.51	0.12	-0.54	-1.17	-1.02	-0.75	-0.37
Free Cash Flow per Basic Share	-2.08	-1.41	-0.49	-0.75	-0.67	-0.85	-0.74	-0.51	-0.53	0.11	-0.57	-1.25	-1.06	-0.77	-0.4
Cash & Equivalents per Share	3.23	1.79	1.7	1.37	1.03	0.78	0.54	0.68	0.32	1.66	4.73	3.41	2.36	1.32	0.93
Book Value per Share	3.48	1.95	1.04	0.74	0.92	0.91	0.74	0.76	0.36	1.74	3.58	2.49	2.62	1.72	0.02
Tangible Book Value per Share	3.48	1.95	1.04	0.74	0.92	0.91	0.74	0.76	0.36	1.74	-0.14	-1.14	-0.81	-0.68	-1.08

Pacific Biosciences of California, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)